What is the difference between the leukemia that Big Brother’s Fury suffers from and Wanda Nara’s diagnosis?

The leukemia (LM) It is a cancer of the blood and bone marrow that is characterized by rapid development and rapidly worsening if left untreated. However, the diagnosis of host and businesswoman Wanda Naraand the participant Big Brother Furypresent some considerable differences.

Juliana “Furia” Scaglione She told her reality show colleagues that she was diagnosed with grade one leukemia. The information was revealed a week after the participant had to leave the house to undergo clinical studies, as the driver Santiago del Moro had reported on his social networks.

This diagnosis It is a form of cancer that affects the white blood cells. Unlike chronic myeloid leukemia, which Nara undergoes, which is characterized by more rapid growth of abnormal cells, grade one involves a slow production of abnormal blood cells.

When in doubt about her continuity in the program, the participant said that does not require treatment, so you won’t have to leave the “most famous house in the country.” Chronic leukemias, which can be myeloid or lymphoid, They are generally less aggressive than acute ones and have a better initial prognosis.

Leukemia: how they are classified and what types there are

There are different types of leukemia, which vary in the development and treatment of the disease. The Acute myeloid leukemia (AML) It affects myeloid cells and develops rapidly. On the other hand, chronic myeloid leukemia (CML) affects myeloid cells but, at first, develops slowly.

Also, there is the lymphoblastic leukemia that affects the lymphoid cells. This It can be acute (ALL) or chronic (CLL), depending on how quickly the disease develops in the patient.

The term “stage 1″, that goes through Fury, no It is a specific type of leukemia but a way of classifying the stage of the disease. CML can be classified into different stages depending on the progression and extent of the cancer in the body. In this case, it is an early diagnosis, where the cancer is still localized.

It is important to keep in mind that each case requires a individualized treatment approach based on several factors, including the patient’s age, general health, and response to treatment.